Maxilac

For treatment of: Maxilac synbiotic & prebiotic intestines, digestive system.

Maxilac Synbiotic

For the treatment of internal organs: intestines, digestive system
Appointment: treatment of dysbiosis
Indications for use:
Maxilac, taking into account the properties, is especially recommended:
— as a prevention of intestinal disorders in the event of climate change, place of stay;
— as a means to normalize the intestinal microflora during and/or after taking medications that may cause changes in the qualitative or quantitative composition of the gastrointestinal microbiocenosis;
— as an adjunct for functional bowel disorders: diarrhea (diarrhea), dyspepsia (digestive disorders), constipation, flatulence (bloating), nausea, belching, vomiting, abdominal pain and discomfort, etc.;
— during seasonal outbreaks of infectious diseases.
Contraindications: — individual intolerance to the product components.
Composition:
The active substance lyophilisate of probiotic bacteria: 4.5 *10^9 CFU, Lactobacillus helveticus 9.00* 10^8 CFU, Lactococcus lactis 9.00* 10^8 CFU, Bifidobacterium longum 6.75 *10^8 CFU, Bifidobacterium breve 4.50* 10^8 CFU, Lactobacillus rhamnosus 4.50 *10^8 CFU, Streptococcus thermophilus 4.50* 10^8 CFU, Bifidobacterium bifidum 2.25 *10^8 CFU, Lactobacillus plantarum 2.25* 10^8 CFU, Lactobacillus casei 2.25 *10^8 CFU, prebiotic component: oligofructose 63 MG Excipients: corn starch gelatinized, corn starch, hydroxypropylmethylcellulose (E464), titanium dioxide (E171), shellac (E904), magnesium stearate (E470B), alginic acid (E400), ascorbic acid (E300), triethylcitrate (E1505), olive oil, carob gum (E410)
Manufacturer: Genexo